CYCN - Cyclerion Therapeutics, Inc. Sof foyda bo'yicha sotuv rentabelligi

cyclerion.com - CYCN emitenti grafik logotipi

Cyclerion Therapeutics yetarli tadqiqot va ishlanmalar (R&D) kapitali hisobiga barqarorlikni saqlamoqda, bu esa GURU.Markets platformasidagi sotuvlarning sof rentabelligi bilan tasdiqlanadi, u yerda joriy daraja -353.00 ni tashkil etadi. Miya bilan bog'liq dori vositalarining diversifikatsiyasi yagona test bilan bog'liq xatarlarni yumshatadi. Bundan tashqari, kompaniya ESG ekologik standartlariga qat'iy rioya qilgan holda, o'z laboratoriyalarida energiyani tejash va emissiyalarni filtrlashni joriy qilmoqda.

cyclerion.com (CYCN) - Sof foyda normasi 04.07.2022dan 09.09.2026gacha

cyclerion.com (CYCN) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi statistikasi:
Kompaniyaning dastlabki tahlili:Cyclerion Therapeutics
Cyclerion Therapeutics ishlab chiqargan mahsulot

Bozor Cyclerion Therapeutics (CYCN) kompaniyasini intensiv tadqiqot va ishlanmalar (R&D) bosqichidagi yuqori xavfli aktiv sifatida baholaydi. Sof daromadlilik barcha operatsion va moliyaviy xarajatlar chegirib tashlanganidan keyin, har bir dollar tushumning qancha qismi foyda ekanligini o'lchaydi. Sotuv marjasini tahlil qilish orqali investor tijorat daromadlari yo'qligida kapitalning sarflanish tezligini ko'rishi mumkin. Bioteknologiya kompaniyasi uchun ushbu ko'rsatkich likvidlikka bo'lgan kritik bog'liqlikni aks ettiradi. Salbiy dinamika zaxiralarning kamayishi bosqichini tasdiqlaydi.

Raqobatdosh kompaniyalar

BIIB: Sotuvning sof marjinal rentabelligi|Sof marja Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Sotuvning sof marjinal rentabelligi|AXSM: Sof foyda normasi|Sof marja acadia-pharm.com (ACAD)|Sotuvning sof marjinal rentabelligi Xenon Pharmaceuticals (XENE)|Sof marja Viking Therapeutics VKTX|Sof foyda normasi SUPN|CPRX - Sof marja|Sof marja Denali Therapeutics|HRMY: Sotuvning sof marjinal rentabelligi|Biohaven - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi AMLX|Trevi Therapeutics, Inc. (TRVI) - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi PRAX (Praxis Medicines)|Anavex Corp - Sotuvning sof rentabelligi|Sof marja CeriBell CBLL|Kompaniya sotuv marjasi Prothena Biosciences (PRTA)|ALEC: Sof foyda bo'yicha sotuv rentabelligi|ANNX - Sotuvning sof marjinal rentabelligi|Omeros Corp. (OMER) - Sof marja|Sof marja Neurogene Inc. (NGNE)|Sof foyda bo'yicha sotuv rentabelligi ACIU|Sof marja VYGR|Sof marja Neumora (NMRA)|SCLX - Sof marja|Sotuvning sof marjinal rentabelligi TVGN (Tevogen Bio Holdings Inc.)|Sof foyda normasi ACOG|Cognition Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|IKT - Sotuvning sof marjinal rentabelligi|SAVA: Sotuvning sof marjinal rentabelligi|Assertio Holdings, Inc. - Sof foyda normasi|COYA (Coya) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi VTGN (Vistagen Therapeutics)|Sof marja Ovid Rx (OVID)|Acumen Pharmaceuticals - Sotuvning sof rentabelligi|Sof marja CervoMed, Inc. CRVO|Sotuvning sof marjinal rentabelligi Alterity Therapeutics ATHE|CLNN: Sof foyda bo'yicha sotuv rentabelligi|PEPG (pepgen.com) - Sotuvning sof rentabelligi|Jupiter Neurosciences Inc (JUNS) - Sof marja|Relmada Therapeutics - Sof foyda normasi|ANVS (Annovis Bio Inc) - Sotuvning sof marjinal rentabelligi|GRCE: Sof foyda normasi|Sof marja Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Sof foyda normasi|Sof marja neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Sof marja|MTVA: Sof foyda bo'yicha sotuv rentabelligi|NeurAxis, Inc (NRXS) - Sof foyda bo'yicha sotuv rentabelligi|HSDT: Sotuvning sof marjinal rentabelligi|PASG - Kompaniya sotuv marjasi|Sof marja Neuphoria Therapeutics, Inc.|Sof marja NERV|Sotuvning sof marjinal rentabelligi ATHA|ADXN (Addex Therapeutics Ltd) - Sof foyda normasi|Sof marja alzamend.com ALZN|Sof foyda bo'yicha marjinallik Protagenic|KTTA: Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi CRGT (cortigent.com)|ATXI: Sotuvning sof marjinal rentabelligi|BCLI (BrainStorm Cell Therapeutics) - Sof marja|CARA (Cara Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sof marja CHRO|Sof foyda bo'yicha sotuv rentabelligi ELYM (Eliem Therapeutics)|Sof marja ITCI (Intra-Cellular Therapies Inc.)|Sotuvning sof marjinal rentabelligi LBPH (Longboard Pharma)|Sotuvning sof marjinal rentabelligi Marinus Pharmaceuticals Inc MRNS|NKGen Biotech Corp - Sotuvning sof marjinal rentabelligi|Sof foyda normasi NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi SNPX|Sof foyda bo'yicha sotuv rentabelligi TRVN|Sof marja VIGL|Sotuvning sof marjinal rentabelligi WENA|Kompaniya sotuv marjasi Cerevel